Claim: Mounjaro (tirzepatide) is significantly more effective for weight loss than Ozempic (semaglutide)

The claim that Mounjaro is significantly more effective for weight loss than Ozempic is mostly true. Multiple studies and real-world data support that tirzepatide leads to greater weight loss compared to semaglutide, with the difference becoming more pronounced over time. However, some sources emphasize that the effectiveness of Mounjaro may depend on continued use, which could lead to weight regain after stopping treatment. This nuance is important as it highlights that while Mounjaro may be more effective, the sustainability of weight loss is a critical factor to consider. Overall, mainstream health sources tend to support the claim, while some alternative perspectives raise concerns about long-term effectiveness and weight maintenance after discontinuation of the drug. All three graders point in the same direction, with minor differences. Gemini comes in highest (95%), while OpenAI is lowest (85%). While the majority of evidence supports the claim that Mounjaro is more effective for weight loss, some sources highlight that stopping the medication can lead to weight regain, which complicates the assessment of its effectiveness. This perspective does not necessarily contradict the claim but adds a layer of complexity regarding the sustainability of weight loss achieved with Mounjaro compared to Ozempic. Therefore, while the evidence leans towards Mounjaro being more effective, the context of long-term weight management must be acknowledged.